Product Information

CEFDINIR 300 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $0.4593 per EA under NDC 60687069921. Its NADAC has been published 163 times since Jul 12, 2023.

FDA first approved this application on Feb 19, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CEFDINIR 300 MG CAPSULE

Cefdinir
$0.4593per EA

Strength

300 mg/1

NDC

60687069921

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CEFDINIR

Approval Type

Generic (ANDA)

FDA Application

ANDA210220

FDA Approved

2/19/2021

TE Code

AB

On Market Since

6/26/2023

Pharmacological Classes

Price Statistics

The NADAC for CEFDINIR 300 MG CAPSULE has been published 163 times since Jul 12, 2023, and over the history we have for it it has declined 7.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4593 per EA
All-time high$0.5078 (Jan 10, 2024)
All-time low$0.3507 (Nov 20, 2024)
52-week high$0.4752
52-week low$0.4551
Median price$0.4699
Average price$0.4641
Largest weekly change-25.5% (Nov 20, 2024)
Weeks tracked163
Tracking sinceJul 12, 2023

Price History

1W

-0.6%

1M

-0.6%

3M

-0.2%

6M

-1.8%

1Y

-1.8%

3Y

-2.5%

5Y

N/A

All

-7.2%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CEFDINIR 300 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 300 MG CAPSULE, manufactured by American Health Packaging, is $0.4593 per EA (NDC 60687069921), effective Aug 19, 2026.

How has the price of CEFDINIR 300 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CEFDINIR 300 MG CAPSULE has declined 7.2%. It has been tracked across 163 weekly CMS publications since Jul 12, 2023.

What are the highest and lowest recorded NADAC prices for CEFDINIR 300 MG CAPSULE?

Since Jul 12, 2023, the NADAC for CEFDINIR 300 MG CAPSULE has ranged from a low of $0.3507 (Nov 20, 2024) to a high of $0.5078 (Jan 10, 2024), with a median of $0.4699 per EA.

Are there cheaper alternatives to CEFDINIR 300 MG CAPSULE?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFDINIR 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures CEFDINIR 300 MG CAPSULE?

CEFDINIR 300 MG CAPSULE (NDC 60687069921) is labeled by American Health Packaging, and CMS classifies it as a generic product.